Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.62 |
| ▸ | HTR1B | P28222 | 2/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.53 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.52 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.52 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.52 |
| ▸ | DRD2 | P14416 | 2/20 | 0.50 |
| ▸ | DRD4 | P21917 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11285757 | 0.89 | KCNA3 (0.58) | KCNA3HTR1BLTA4HCHRNB2CHRNB4 | |
| SCHEMBL21367950 | 0.82 | KCNA3 (0.68) | KCNA3HTR1BLTA4HCHRNB2CHRNB4 | |
| SCHEMBL6535231 | 0.82 | KCNA3 (0.68) | KCNA3HTR1BLTA4HCHRNB2CHRNB4 | |
| SCHEMBL3099934 | 0.79 | DRD4 (0.50) | LTA4HCHRNA7DRD2DRD4ALDH1A1 | |
| SCHEMBL12015520 | 0.79 | DRD2 (0.55) | DRD2DRD4ALDH1A1DRD3L3MBTL1 | |
| SCHEMBL1025 | 0.78 | KCNA3 (0.88) | KCNA3HTR1BLTA4HCHRNB2CHRNB4 | |
| SCHEMBL1490164 | 0.78 | KCNA3 (1.00) | KCNA3HTR1BLTA4HDRD2DRD4 | |
| SCHEMBL14814295 | 0.77 | KCNA3 (0.36) | KCNA3HTR1BLTA4HCHRNB2CHRNB4 | |
| SCHEMBL3360240 | 0.77 | KCNA3 (0.52) | KCNA3HTR1BLTA4HCHRNB2CHRNB4 | |
| SCHEMBL497029 | 0.76 | KCNA3 (0.94) | KCNA3HTR1BLTA4HDRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2711381-B1 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, AND CURED PRODUCT | MITSUI CHEMICALS INC (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-20100279509-A1 | Silicon-based hardmask composition and process of producing semiconductor integrated circuit device using the same | SAMSUNG SDI CO., LTD. (KR) | 2010-11-04 | — | — | US | disclosed |
| US-20030229113-A1 | Keratinocyte growth inhibitors and hydroxamic acid derivatives | AKZO NOBEL N.V. (NL) | 2003-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229113-A1 | Keratinocyte growth inhibitors and hydroxamic acid derivatives | FGF1, FGF2, EGFR | KCNA3 2951/4885HTR1B 3638/4885LTA4H 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.